Diagnostics and Tools March 2023

Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.

Highlights from this edition:

• SYNLAB AG (DB:SYAB) was acquired by Civen Limited
• Sartorius Stedim Biotech S.A. (ENXTPA:DIM) announced its acquisition of Polyplus-transfection SA
• synaptive Medical Inc. has closed a $50MM Series A Financing, led by Export Development Canada